Planchenault D, Martin-Coignard D, Rugemintwaza D, Bah A-G, Cosson L, Labarthe F, Chantepie A, Saliba E
Service de réanimation néonatale et pédiatrique, CHRU de Tours, hôpital Clocheville, 49, boulevard Béranger, 37044 Tours cedex 9, France.
Service de génétique médicale et cytogénétique, centre hospitalier du Mans, 194, avenue Rubillard, 72037 Le Mans cedex 9, France.
Arch Pediatr. 2014 Feb;21(2):206-10. doi: 10.1016/j.arcped.2013.11.016. Epub 2014 Jan 1.
Donohue syndrome or leprechaunism is a severe congenital insulin-resistance syndrome. It is characterized by intra-uterine and neonatal growth retardation, typical dysmorphic features, and metabolic abnormalities with hyperinsulinism and hyperandrogenism. Problems in energy metabolism and loss of glucose homeostasis are responsible for early death in the first year of life. We describe a case with a novel homozygote mutation in the insulin receptor gene. This patient had hypertrophic cardiomyopathy with heart failure and bronchial compression leading to clinical deterioration over 5 days and subsequently death. A treatment with recombinant IGF-1 was tried without efficacy.
多诺霍综合征或妖精貌综合征是一种严重的先天性胰岛素抵抗综合征。其特征为宫内和新生儿生长发育迟缓、典型的畸形特征以及伴有高胰岛素血症和高雄激素血症的代谢异常。能量代谢问题和葡萄糖稳态的丧失是导致出生后第一年早期死亡的原因。我们描述了一例胰岛素受体基因发生新型纯合突变的病例。该患者患有肥厚型心肌病并伴有心力衰竭和支气管受压,导致在5天内临床病情恶化,随后死亡。尝试使用重组胰岛素样生长因子-1进行治疗但无效。